Cargando…
Dermatofibrosarcoma protuberans – the use of neoadjuvant imatinib for treatment of an uncommon breast malignancy: a case report
BACKGROUND: Dermatofibrosarcoma protuberans is a rare soft tissue malignancy that, if left untreated, can be locally destructive and life-threatening. Dermatofibrosarcoma protuberans is uncommon in the breast, and the similarity of its morphologic features with other spindle cell malignancies can ma...
Autores principales: | McGee, Matthew W., Boukhar, Sarag A., Monga, Varun, Weigel, Ronald, Phadke, Sneha D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921555/ https://www.ncbi.nlm.nih.gov/pubmed/31852518 http://dx.doi.org/10.1186/s13256-019-2316-0 |
Ejemplares similares
-
Imatinib in the treatment of dermatofibrosarcoma protuberans
por: Labropoulos, Stefanos V, et al.
Publicado: (2007) -
Dermatofibrosarcoma Protuberans at an Uncommon Site
por: Sardesai, Vidyadhar R., et al.
Publicado: (2014) -
Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature
por: Dhir, Mashaal, et al.
Publicado: (2014) -
Recurrent dermatofibrosarcoma protuberans treated with neoadjuvant imatinib mesylate followed by Mohs micrographic surgery
por: Fontecilla, Natalia M., et al.
Publicado: (2017) -
Abscopal Effect of Radiotherapy in Imatinib-resistant Dermatofibrosarcoma Protuberans
por: Agyeman, Mervin B, et al.
Publicado: (2019)